Meyka Pro banner
Protagonist Therapeutics, Inc.

PTGX Technical Analysis Summary (NASDAQ)

Analyze PTGX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

PTGX●NASDAQ
HealthcareBiotechnology
$130.95
$3.43(2.55%)
U.S. Market opens in 3h 50m

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

PTGX Technical Analysis Summary (NASDAQ)

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stock currently shows a bearish trend on the NASDAQ, supported by momentum and weak buying pressure.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 39.26)
Trend Strength:Moderate (ADX: 21.72)
Volatility:Medium (ATR: 5.85)
Support/Resistance:$130.68 – $145.77 (Bollinger Bands)

Technical conditions suggest Protagonist Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Overall, Protagonist Therapeutics, Inc. remains neutral, with indicators showing mixed momentum.

Momentum Indicators

RSI (14): 39.26

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 30.33

Bearish
Momentum remains weak below midpoint.

Williams %R: -80.80

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -6.26

Strongly Bearish
Sharp downside momentum.

Takeaway:Protagonist Therapeutics, Inc. shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: -1.87

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 21.72

Moderate
Moderate trend, direction gaining strength.

ATR (14): 5.85

High
High volatility, wide price fluctuations.

CCI (14): -108.98

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Protagonist Therapeutics, Inc. shows oversold trend conditions, with potential for rebound if buyers step in.

Support & Resistance indicators
Bollinger Bands
Upper Band
$145.77
Middle Band (SMA 20)
$138.22
Lower Band
$130.68
Current Position
Within Bands

Takeaway:Protagonist Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$149.13
Middle Line (EMA 20)
$137.43
Lower Channel
$125.72
Squeeze Status
Squeeze On

Takeaway:Protagonist Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume1.34M
Money Flow Index50.96Neutral, balanced money flows with no clear signal.
Relative Vigor Index43.58Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:PTGX shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Protagonist Therapeutics, Inc. (NASDAQ: PTGX), here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Protagonist Therapeutics, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.

(NASDAQ: PTGX) Technical Analysis FAQ